Bioequivalence study of rabeprazole sodium on healthy human volunteers

Journal of the Indian Medical Association

Volumn 102, Issue 1, 2004, Pages 26-30

  Mondal, U ^a   Ganesan, M ^a   Pal, T K ^a   Jayakumar, M ^a   Chattaraj, T K ^b   Roy, K ^b   Banerjee, S N ^c  

^a JADAVPUR UNIVERSITY   (India)

^b NRS MEDICAL COLLEGE   (India)

^c WBMES   (India)

Author keywords

Bioequivalence; High performance liquid chromatography (HPLC); Pharmacokinetics; Rabeprazole sodium

Indexed keywords

PROTON PUMP INHIBITOR; RABEPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ADENOSINE TRIPHOSPHATASE; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; OMEPRAZOLE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INDIA; MALE; NORMAL HUMAN; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ULTRAVIOLET RADIATION; BLOOD; DOSE RESPONSE; DRUG ANTAGONISM; PHARMACOKINETICS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADENOSINE TRIPHOSPHATASES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; OMEPRAZOLE; PROTON-TRANSLOCATING ATPASES; THERAPEUTIC EQUIVALENCY;

EID: 4344686913     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. (+)-ATPase by sodium 2-[(4-(3-methoxypropoxy)-3 methylpyridin-2-yl methylsulfinyl]-1H-benzimidazole (E 3810). Chem Pharm Bull (Tokyo) 1996; 44: 552-8.
2. Keane WF, Swan SK, Grimes I, Humphries TJ - Rabeprazole: pharmacokinetics and tolerability in patients with stable end-stage renal failure. J Clin Pharmacol 1999; 39: 927-33.
3. Yasuda S, Higashi S, Murakami M, Tomono Y, Kawaguchi M - Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor in healthy volunteers. Int J Clin Pharmacol Ther 1999; 37: 249-53.
4. Mano N, Oda Y, Takakuwa S, Chiku S, Nakata H, Asakawa N - Plasma direct injection high performance liquid chromatographic method for simulataneous determination of E3810 enantiomers and their metabolites by using flavoprotein-conjugated column. J Pharm Sci 1996; 85: 91-6.
5. Mandal U, Ganesan M, Jayakumar M, Pal TK, Chattaraj TK, Ray K, et al - High performance liquid chromatographic determination of cox-2 inhibitor rofecoxib in human plasma. J Indian Med Assoc 2003; 101: 486-8.
6. Nakai H, Shimamura Y, Kanazawa T, Yasuda S, Kayano M - Determination of a new H(+)-K+ ATPase inhibitor (E 3810) and four metabolites in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994; 660: 211-20.